Robles BioCeutics Welcomes Experienced Drug Developer Dr. Radu Pislariu to Scientific Advisory Board
Accomplished Healthcare Entrepreneur to Help Guide Strategic Growth as Regenerative Dermatology Company Prepares for Clinical Trials
SAN DIEGO, April 22, 2025 /PRNewswire/ -- Robles BioCeutics, a regenerative dermatology biotechnology company pioneering next-generation skincare solutions using stem cell and senolytics technologies, is pleased to welcome Dr. Radu Pislariu to its scientific advisory board.
Robles BioCeutics' lead product, GlowSelle™ is a patent-pending regenerative formulation based on molecules and exosomes released from proprietary stem cells that are activated using the Company's "Injury Mimetic™" technology[1].
"Maria represents the next generation of bold, visionary women entrepreneurs who are not only redefining what's possible in science, but also how innovation is brought to market," said Dr. Radu Pislariu. "Robles BioCeutics potential to translates complex biotechnology into impactful solutions for skin health is inspiring. I'm excited to support Maria and the Robles BioCeutics team as they work to bring a new era of regenerative dermatology to life."
Dr. Radu Pislariu is an experienced healthcare entrepreneur and investor, with extensive medical and drug development expertise. Radu is currently the Co-founder and CEO of Canada-based Laurent Pharmaceuticals, a private biotechnology company in advanced clinical stage, and the Co-Founder and President of Fundry Inc, an accelerator focusing on innovation transfer and biotech start-up structuring. Previously an investment professional with iNovia Capital, a Venture Capital firm with now over US$2.5 billion dollars under management, Radu led multiple transactions and financing rounds, provided entrepreneurial support and served on the board of directors of several biotech companies. Radu is a medical doctor and holds graduate diploma in Drug Development from the Université de Montréal and a graduate diploma in Management from Hautes Études Commerciales in Montreal. His diverse background and experience equip him with a unique blend of medical, scientific, and business acumen, making him a valuable addition to the Robles BioCeutics scientific advisory board.
"I am honored to welcome Dr. Radu Pislariu to the Robles BioCeutics advisory board," said Maria Robles, CEO and President. "His extensive background in medical science, drug development, and strategic leadership aligns seamlessly with our mission to transform skin health through regenerative science. As a seasoned healthcare entrepreneur and investor, Dr. Pislariu brings a unique perspective that will help guide our innovation pipeline and support the growth of our research and industry collaborations."
Dr. Pislariu joins an esteemed cadre of medical and business luminaries on the Scientific Advisory Board including Dr. Navneet Boddu, Howard Leonhardt, Maxim Wheatley, and Dr. Feng Lin.
About Robles BioCeutics Robles BioCeutics is a regenerative dermatology company focused on developing innovative, science-backed solutions for skin health and longevity. Founded by Maria Robles, the company leverages breakthrough advancements in stem cell technology and senolytics to create products that support the skin's natural renewal and repair processes.
For updates, follow Robles BioCeutics on Instagram, Twitter, Facebook, and Youtube, or visit us at https://roblesbioceutics.com.
For more information, please contact: Maria Robles
CEO and President
Robles BioCeutics
393785@email4pr.com
858-609-0948